Class III medical devices subject to clinical trials 2020

n September 18, the national medical device administration issued the catalogue of class III medical devices subject to clinical trial approval (2020) and its revision instructions. Compared with the 2014 edition, the catalog added the description of common principles of applicable products, adjusted 6 catalogue product descriptions, deleted 2 products and updated classification codes. Add general principle description of applicable products, that is, “compared with the products already on the market at home and abroad, the medical devices which adopt new design, materials or mechanism, and / or are suitable for new application scope and have higher risk to humanRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field